Close Menu

Merger Madness

As everyone is busy filling out their March Madness Brackets (and hoping that Duke loses), the Health Blog at the Wall Street Journal has come up with a bracket of their own, seeding pharmas against one another. Some of the results are already in -- Pfizer's taken down Wyeth and Roche's beaten Genentech -- but the winner of the "merger mania" isn't yet clear.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.